China SXT Pharmaceuticals income statement data for the quarter ended Mar 2026. This income statement covers 1 quarter of results, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2026 |
|---|---|
| Additional items | |
| Shares Outstanding | 8,496.00 |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 8,496.00 |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 13,123.00 |